Context: Solid lipid nanoparticles (SLN) are regarded as interesting drug delivery systems and their preparationtechniques have gained a great deal of attention.Objective: To evaluate the feasibility of preparing idebenone (IDE) loaded SLN from O/W microemulsions by thephase-inversion temperature (PIT) method. Since SLN have been proposed to improve drug delivery to the brain, IDEwas chosen as model drug due to its activity in the treatment of neurodegenerative diseases.Materials and Methods: Cetyl palmitate was used as solid lipid to prepare SLN containing two surfactant/cosurfactantmixtures, isoceteth-20/glyceryl oleate (SLN A) and ceteth-20/glyceryl oleate (SLN B) by the PIT method.Results and discussion: All the formulations tested showed a mean particle diameter ranging from 30 to 95 nm anda single peak in size distribution. Stability tests showed that SLN B were more stable than SLN A. IDE release wasdependent both on the type of primary surfactant used and the amount of loaded drug. IDE-loaded SLN wereeffective in inhibiting 2,2’-azobis-(2-amidinopropane)dihydrochloride (APPH)-induced lactic dehydrogenase (LDH)release and reactive oxygen species (ROS) production in primary cultures of astrocytes obtained from rat cerebralcortex. It is noteworthy that SLN B2 (containing ceteth-20 as primary surfactant and 0.7% w/w IDE) were able toprevent entirely both the LDH release and ROS production induced by APPH.Conclusion: The PIT method provided SLN with good technological properties. The tested SLN could be regarded asinteresting carriers to overcome the blood brain barrier and increase the efficacy of the loaded drug.
solid lipid nanoparticles; idebenone; PIT; in vitro release; biologicalactivity.Page 2 of 41
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
MONTENEGRO, LUCIA;CAMPISI, Agatina;SARPIETRO, MARIA GRAZIA;CARBONE, CLAUDIA;ACQUAVIVA, ROSARIA;RACITI, Giuseppina;PUGLISI, Giovanni
Abstractsolid lipid nanoparticles; idebenone; PIT; in vitro release; biologicalactivity.Page 2 of 41
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.